Clinical Trial

Efficacy and Safety of Local Glucocorticoids for the Treatment of Acute Radiation-Induced Intestinal Injury

Recruiting
View on ClinicalTrials.gov →
Summary
Due to the increasing number and prolonged survival of malignant tumor patients treated with radiotherapy, the complication, such as acute radiation-induced intestinal injury, has become increasingly significant. Glucocorticoids may play a therapeutic role by regulating the inflammatory response in patients with acute radiation-induced intestinal injury. However, the conclusions of related studies were controversial.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-07; most recent amendment 2025-12-17.
Status change: Not Yet Recruiting → Recruiting 2024-08-05
Trial Details
NCT Number NCT06410443
Lead Sponsor General Hospital of Shenyang Military Region
Conditions Radiation-Induced Intestinal Injury
Enrollment 60 participants
Start Date 2024-08-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-24